Literature DB >> 15931306

Maximally utilizing the available agents for the treatment of type 2 diabetes.

David S H Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15931306      PMCID： PMC1069042          DOI： 10.3121/cmr.1.3.173

Source DB:  PubMed          Journal:  Clin Med Res        ISSN： 1539-4182


× No keyword cloud information.
  5 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Why I initiate therapy with two insulin sensitizers in patients with type 2 diabetes.

Authors:  David S H Bell
Journal:  Endocr Pract       Date:  2003 Jan-Feb       Impact factor: 3.443

3.  Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

Authors:  L Avilés-Santa; J Sinding; P Raskin
Journal:  Ann Intern Med       Date:  1999-08-03       Impact factor: 25.391

Review 4.  Current therapeutic options in type 2 diabetes mellitus: a practical approach.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2003-07

5.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk).

Authors:  K T Khaw; N Wareham; R Luben; S Bingham; S Oakes; A Welch; N Day
Journal:  BMJ       Date:  2001-01-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.